Poster Hall

Minichmayr IK¹, Uster DW², Fellhauer M³, König C⁴, Langebrake C⁵, Wicha SG^{2 1}Dept. of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; ²Dept. of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Germany; ³Hospital Pharmacy, Schwarzwald-Baar Hospital, Villingen-Schwenningen, Germany; ⁴Hospital Pharmacy and Dept. of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany; ⁵Hospital Pharmacy and Dept. of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Imai S¹, Takekuma Y², Kashiwagi H¹, Miyai T³, Sugawara M^1,2 1. Faculty of Pharmaceutical Sciences, Hokkaido University, 2. Department of Pharmacy, Hokkaido University Hospital, 3. Graduate School of Life Science, Hokkaido University

Balloch SA, Calton LJ, Hammond GW

Mochizuki T ¹, Shibata K ¹, Naito T ¹, Shimoyama K ², Ogawa N ², Kawakami J ^1
1 Department of Hospital Pharmacy, Hamamatsu University School of Medicine
² Department of Rheumatology, Hamamatsu University School of Medicine

Kupa LVK³, Romano P^1,2, Almeida REP^1,2, Duarte NJC^1,2, Chalom MY¹. ¹Central Laboratory Division, ²Laboratório de Investigação Médica (LIM 03), ³Laboratório de Investigação Médica (LIM 17), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil

Seraphim JC¹, Amaral ACS¹, Kupa LVK¹, Romano P^2,3, Chalom MY², Almeida REP^2,3, Duarte NJC^2,3, Carvalho VM⁴, Silva CA¹, Bonfa E¹Rheumatology Division Hospital das Clínicas HCFMUSP ² , Central Laboratory Division, ³Laboratório de Investigação Médica (LIM 03), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo ⁴Grupo Fleury, São Paulo, SP, BR.

Santhosh S¹, Winston B¹, Christopher DJ², Prabha R¹, Mathew S¹, Mohan D², Mathew BS^1
1Clinical Pharmacology Unit, Department of Pharmacology and Clinical Pharmacology, CMC Vellore.
²Department of Pulmonary Medicine, CMC Vellore.

Roydhouse S.A.^{1, 2}, Carland J.E.^{1, 2}, Debono D.S.³, Baysari M.T.⁴, Staciwa A.⁵, Sandhu A.⁵, Day R.O.^1,2,6, Stocker S.L.^{1, 2
1}St Vincent’s Clinical School, The University of New South Wales, Sydney, Australia
²Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital Sydney, Sydney, Australia
³Centre for Health Services Management, Faculty of Health, The University of Technology Sydney, Sydney, Australia
⁴Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
⁵Pharmacy Department, St Vincent’s Hospital Sydney, Sydney, Australia
⁶School of Medical Sciences, The University of New South Wales, Sydney, Australia

Schneider, R, Bhandari, M, Lavin, Y.
Abbott Diagnostics

Outeda-Macías M, Salvador-Garrido P, Elberdín-Pazos L, Martín-Herranz I.
Pharmacy Department. A Coruña University Hospital Complex. Área Sanitaria da Coruña e Cee. A Coruña. Spain.

Kupa LVK¹, Duarte NJC^2,3, Seraphim JC¹, Duarte AJS^2,3, Romano P^2,3, Martins VAO¹, Pedrosa TN¹, Pasoto SG¹, Aikawa NE¹, Carvalho VM⁴, Silva CA¹, Bonfa E¹.
¹Rheumatology Division, ²Central Laboratory Division, ³Laboratório de Investigação Médica (LIM 03), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, ⁴Grupo Fleury, São Paulo, SP, Brazil

^{1, 2} Anetor, J. I*. ¹ MacDonald A, ¹Huang D, ³Ikeh- Tarawali, P, ⁴Charles- Davis, M. A., ⁵Arowojolu, A; ¹Kinniburgh, D. W
¹Alberta Centre For Toxicology, Cumming School of Medicine, University of Calgary, Canada
²Laboratory for Toxicology & Micronutrient Metabolism, Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan
³Department of Chemical Pathology, Niger Delta University, Bayelsa, State, Nigeria
⁴Endocrinology Unit, Department of Chemical Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria
*Correspondence

Aouad H.¹, Sauvage FL.¹, Di Meo F.¹, Marquet P.^1,2, Essig M.^3
1IPPRITT UMR-1248 INSERM, Faculty of Medicine, Limoges, France
²Department of pharmacology and toxicology, CHU Limoges, Limoges, France
³APHP, Ambroise Paré Hospital, Nephrology Departement, 92100 Boulogne Billancourt, France

Stern M¹, Giebels M², Fey T², Lübking M³, Alferink J³, Hempel G^1
1 Department of Pharmaceutical and Medical Chemistry – Clinical Pharmacy, University of Münster, Corrensstraße 48, 48149 Münster, Germany
² Geriatric Psychiatry, LWL-Klinik, Friedrich-Wilhelm-Weber-Straße 30, 48147 Münster, Germany
³ Damian-Klinik, Alexianer Münster GmbH, Alexianerweg 9, 48163 Münster, Germany

Christian Cooper¹, Kayleigh Davis¹, Matthew Atkins², David Taylor², Philip McGuire³, Irina Baburina⁴, Salvatore Salamone⁴, Dave Berry^1
1Viapath Toxicology,Kings College Hospital, ²Maudsley Hospital , ³Institute of Psychiatry, King’s College, ⁴Saladax Biomedical, Inc.

Martial LC[1], Olyslager E[2], Den Burger JCG[1], Wieferink J[2], Franssen EJF[1], Van Gendt-de Jong LAA [2].
[1] Department of Hospital Pharmacy, OLVG, Amsterdam, The Netherlands; [2] Department of Hospital Pharmacy, Gelre Ziekenhuizen, Apeldoorn/Zutphen, The Netherlands.

M. Steffi Aswini Maria, Ratna Prabha, Binu S Mathew, Sumith K. Mathew, Susanne Pulimood1,Dincy Peter C.V1, Gauri Mahabal1
Department of Pharmacology and Clinical Pharmacology,
1Department of Dermatology, CMC Vellore

Ye J., Zhang X., Huang D. Y., Kinniburgh D. W.
Alberta Centre for Toxicology, Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

Daan van de Velde, BSc^a; Jordy L. van der Graaf, BSc^a; M. Boussaidi^a; R. Huisman^a; Dennis A. Hesselink, PhD^b; H. Russcher, PhD^c; Erik van Maarseveen, PhD^d; Brenda C.M. de Winter, PhD ^a
aDepartment of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands
^bDepartment of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands
^cDepartment of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands
^dDepartment of Hospital Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands

Nanga TM.¹, Bouriah S.¹, Woillard JB.², Rousseau A.¹, Marquet P.², Musuamba FT.³, Prémaud A.^1
1IPPRITT UMR-1248 INSERM, Université de Limoges – Limoges (France)
²IPPRITT UMR-1248 INSERM, CHU de Limoges, Université de Limoges – Limoges (France)
³Federal Agency for Medicines and Health Products – Brussels (Belgium)

Ye J., Zhang X., Huang D. Y., Kinniburgh D. W.
Alberta Centre for Toxicology, Physiology & Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

Aaryashree, Yuuto Takeda, Momoe Kanai, Yasuo Yoshimi
Department of Applied Chemistry, Shibaura Institute of Technology and Technology

Authors: Roelofsen^a  E. E. de Winter^b B.C.M., Abdulla^b A., Endeman^c H., Dijkstra^d A., Muller^e,f A. E., Koch^b B. C.P.
^a Department of Hospital Pharmacy, Haaglanden Medical Centre, The Hague, The Netherlands.
^b Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
^c Department of Intensive Care, Erasmus University Medical Center, Rotterdam, The Netherlands.
^d Department of Intensive Care, Maasstad Hospital, Rotterdam, The Netherlands.
^e Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.
^f Department of Medical Microbiology, Haaglanden Medical Centre, The Hague, The Netherlands.

Du W¹, Wang X¹, Zhang D¹, Chen W¹, Wang X¹, Zhang X¹, Chen W², Li P^1
1 Department of Pharmacy, China-Japan Friendship Hospital, Beijing, China
² Department of Lung Transplantation, China-Japan Friendship Hospital, Beijing, China

Degraeve A^1,4, Stillemans G^1,2, Moudio S¹, El-Hamdaoui H¹, Delongie K-A³, Haufroid V^2,3, Bindels L⁴, Elens L^1
1Department of Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, LDRI, UCLouvain, Belgium
² Louvain Centre for Toxicology and Applied Pharmacology, IREC, UCLouvain, Belgium
³ Department of Clinical Chemistry, Saint-Luc university clinics, Belgium
⁴ Metabolism and Nutrition Research Group, LDRI, UCLouvain, Belgium

Suzuki Y.¹, Yoshihashi T.¹, Takahashi K.², Oda T.², Homma M.^1,3
1Department of Pharmacy, University of Tsukuba Hospital
²Department of Gastrointestinal and Hepato-biliary-pancreatic, and Transplantation Surgery, Faculty of Medicine, University of Tsukuba
³Department of Pharmaceutical Sciences, Faculty of Medicine, University of Tsukuba

Estimation of the under area the concentration-time curve of polymyxin B based on limited sampling concentrations in Chinese patients with severe pneumonia
Wenqian Chen¹, Huifang Liu¹, Qianlin Wang², Xiaoxing Wang¹, Xudong Kong¹, Xiaoxue Wang¹, Xianglin Zhang¹, Qingyuan Zhan²,Pengmei Li¹*
(1.Department of pharmacy, China-Japan Friendship Hospital, Beijing 100029; 2. Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029)

Zhiyao Chen^a,‡, Shichao Zhang^a,‡, Cheng Ding^b, Chang Li^b, Jun Chen^b, Jun Zhao^{b, *} and Liyan Miao^{a, *
a} Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China.
^b Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, PR China.
^‡These authors contributed equally to this work.
^*Author for correspondence.

Nick Verougstraete^1,2, Marthe Vandeputte¹, Cathelijne Lyphout³, Annelies Cannaert¹, Fabian Hulpia⁴, Serge Van Calenbergh⁴, Alain G. Verstraete^2,5, Christophe Stove^1
1: Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
²: Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium
³: Emergency Department, Ghent University Hospital, Ghent, Belgium
⁴: Laboratory for Medicinal Chemistry, Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
⁵: Department of Diagnostic Sciences, Ghent University, Ghent, Belgium

Verdier Mc^1,2,3, Houssel P⁴, Lemaitre F^1,2,3, Verin M¹, Tron C^1,2,3, Lalanne S^1,2,3, Renac V⁵, Boudjema K^4,6, Bellissant E^1,2,3
1 CIC 1414 (Clinical Investigation Center), INSERM, Rennes, France.
2 Clinical Pharmacology Department, CHU Rennes, Rennes, France.
3 Experimental and Clinical Pharmacology Laboratory, Univ Rennes, Rennes, France.
4 Department of Hepatobiliary and Digestive Surgery, University Hospital, Rennes 1 University, Rennes, France.
5 Etablissement Français du Sang Bretagne, HLA Laboratory, Rennes, France.

Zhang X, Ye J, Huang D.Y, Kinniburgh D.W.
Alberta Centre for Toxicology, University of Calgary, Calgary, Alberta, Canada

Maillard M.¹, Langevin M.², Ciccolini J.³, Etienne MC.⁴, Tafzi N.⁵, Launay M.⁶, Richard D.⁷, Gautier E.⁸, Royer B.⁹, Narjoz C.¹⁰, Haufroid V.¹¹, Bouges H.⁴, Picard N.⁵ , Barin-Le Guellec C.^2,12, Thomas F.^1,13
1Centre de Recherches en Cancérologie de Toulouse, Inserm UMR1037, Université Paul Sabatier, Toulouse, France, ²Université de Tours, Tours, France, ³AP-HM Hôpital La Timone, Marseille, France, ⁴Centre Antoine Lacassagne, Nice, France, ⁵CHU de Limoges, Limoges, France, ⁶CHU de Saint-Etienne, Saint-Etienne, France, ⁷CHU de Clermont-Ferrand, Clermont-Ferrand, France, ⁸CHU de Dijon-Bourgogne, Dijon, France, ⁹CHU Jean-Minjoz, Besançon, France, ¹⁰Hôpital Européen Georges Pompidou, Paris, France, ¹¹Cliniques Universitaires Saint Luc, Bruxelles, Belgique, ¹²CHU Bretonneau, Tours, France, ¹³Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France

Lina Keutzer and Ulrika SH Simonsson
Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

Houwen J,^1,2 Egberts A, ^1,2 de Boer A,^2,3 Maarseveen E,¹ Houwen R,⁴ Lalmohamed A.^1,2
1University Medical Center Utrecht, Department of Clinical Pharmacy Utrecht, Netherlands
²Utrecht University, Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands
³Dutch Medicines Evaluation Board (CBG/MEB), Utrecht, Netherlands
⁴University Medical Center Utrecht, Department of Paediatric Gastroenterology, Utrecht, Netherlands

Salvador-Garrido P, Outeda-Macías M, Fernádez-Rivera C¹, Elberdin-Pazos L, Martín-Herranz I.
Pharmacy Service. ¹Nephrology Service. A Coruña University Hospital. Área Sanitaria da Coruña e Cee.  A Coruña. Spain.

Wu Y, Li H, Wang L, Deng X, Wang X, Shi T
Department of Pharmacy, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001,P.R. China

Mathew SK, Rao SV^*, Prabha R, Aruldhas BW, Subramani K^*, Mathew BS
Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, Tamil Nadu, India, ^*Surgical Intensive Care Unit and Division of Critical Care, Christian Medical College, Vellore, Tamil Nadu, India

M. Molinaro1, N. Decembrino2, B.M. Goffredo3, S. De Gregori1, I. Giardini1, S. Cairoli3, K. Perruccio4, A. Colombini5, E. Calore6, P. Muggeo7, E. Soncini8, A. Comelli9, L. Scudeller11, M. Zecca2, S. Cesaro10
1Clinical & Experimental Pharmacokinetics Unit – Fondazione IRCCS Policlinico San Matteo – Pavia
2Dept. of Hematology/Oncology – Fondazione IRCCS Policlinico San Matteo – Pavia
3Lab. of Metabolic Pathology – Ospedale Pediatrico Bambino Gesù – Roma
4Div. of Pediatric Hematology – University Hospital of Perugia – Perugia
5Pediatric Hematology/Oncology – Fondazione Monza e Brianza per il Bambino e la Mamma – Monza
6Pediatric Hemato-Oncology, Dept. of Women’s and Children Health, University Hospital of Padova – Padova
7Dept. of Pediatric Oncology and Hematology, University Hospital of Policlinico – Bari
8Pediatric Hematology/Oncology – Spedali Civili – Brescia
9Dept. of Infectious and Tropical Diseases – Spedali Civili – Brescia
10Clinical Epidemiology and Biometric Unit, Scientific Direction – Fondazione IRCCS Policlinico San Matteo – Pavia
11Pediatric Hematology/Oncology – Azienda Ospedaliera Universitaria Integrata – Verona

Tim Ewoldt¹, Alan Abdulla², Diederik Gommers¹, Anouk Edwina Muller^3,4, Henrik Endeman¹, Birgit Koch^2
1Erasmus University Medical Center, Department of Intensive Care, Rotterdam, Netherlands,
²Erasmus University Medical Center, Department of Hospital Pharmacy, Rotterdam, Netherlands,
³Erasmus University Medical Center, Department of Medical Microbiology and Infectious Diseases, Rotterdam, Netherlands,
⁴Haaglanden Medical Center, Department of Medical Microbiology, Den Haag, Netherlands

Anetor JI* ^1,2, Adeleke FN², Ajose OA ³, Olaniyan-Taylor GO¹, Fasola FA ⁴, Anetor GO ^5
1Alberta Centre For Toxicology, Cumming School of Medicine, University of Calgary, Calgary, Canada
²Laboratory for Toxicology and Micronutrient Metabolism, Chemical Pathology Department, College of Medicine, University of Ibadan, Nigeria
³Department of Chemical Pathology, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria
⁴Department of Haematology, College of Medicine, University of Ibadan, Nigeria
⁵Health Education Unit, Department of Human Kinetics & Health Education, National Open University of Nigeria (NOUN), Abuja, Nigeria
*Correspondence

Florian Lemaitre^1,2, Camille Tron^1,2, Sebastien Lalanne^1,2, Marie-José Ferrand-Sorre^1,2 et Marie-Clémence Verdier^1,2
1Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, F-35000 Rennes, France
²INSERM, Centre d’Investigation Clinique, CIC 1414, F-35000 Rennes, France

Zwart TC (1), Moes DJAR (1,2), van der Boog PJM (3), van Erp NP (4), de Fijter JW (3), Guchelaar HJ (1,2), Keizer RJ (5), ter Heine R (4)
(1) Leiden University Medical Center, Department of Clinical Pharmacy and Toxicology, Leiden, The Netherlands
(2) Leiden Network for Personalized Therapeutics, Leiden, The Netherlands
(3) Leiden University Medical Center, Department of Internal Medicine (Nephrology), Leiden, The Netherlands
(4) Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Pharmacy, Nijmegen, The Netherlands
(5) Insight RX, San Francisco, CA, USA

Shimamoto Y¹, Mizuno T^2,3, Verstegen R¹, Allen U⁴, Ito S^1,5
1 Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Canada
2 Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
3 Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, USA
4 Division of Infections Disease, The Hospital for Sick Children, Toronto, Canada
5 Department of Pediatrics, University of Toronto, Toronto, Canada

Bourgogne E^1,2, Grondin C ³, Magreault S⁴, Beauxis Y¹, Genta-Jouve G^1,5
 1 Université de Paris, faculté de Pharmacie, UMR 8038, Paris, France, ² Hôpital Saint Antoine, Paris, France, ³ Hôpital Lariboisière, Paris, France ⁴ Hôpital Jean Verdier, Paris, France, ⁵ USR 3456 CNRS LEEISA, Guyane, France

BERTHIER Joseph^a,b, BENMAMERI Mehdi^a, SAUVAGE François-Ludovic^a, FABRE Gabin^a, CHANTEMARGUE Benjamin^c, MARQUET Pierre^a,b, TROUILLAS Patrick^a,d , PICARD Nicolas^a,b , SAINT-MARCOUX Franck^a,b
a INSERM, UMR 1248, Univ. Limoges, rue du Pr Descottes, F-87000 Limoges, France;
^b CHU Limoges, Service de pharmacologie, toxicologie et pharmacovigilance, rue du Pr Descottes, F-87000 Limoges, France;
^c INSILIBIO, 1 avenue Ester Technopôle, 87069 Limoges Cedex, France;
^d RCPTM, Univ. Palacký of Olomouc, tr. 17. listopadu 12, 771 46 Olomouc, Czech Republic

Taylor, Z.L.^1,2,3, Mizuno, T. ^3,4, Punt, N.C.⁵, Baskaran, B.⁶, Navarro Sainz, A.⁶, Shuman, W.⁶, Felicelli, N.⁶, Vinks, A.A.^2,3,4, Heldrup, J.⁷, Ramsey, L.B. ^2,3,4
1 Department of Molecular, Cellular, and Biochemical Pharmacology, University of Cincinnati, Cincinnati, OH
² Division of Research in Patient Services, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
³ Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
⁴ Department of Pediatrics, University of Cincinnati, Cincinnati, OH
⁵ Medimatics, Maastricht, The Netherlands
⁶ Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
⁷ Department of Pediatrics Oncology, Lund University Hospital, Lund, Sweden

Geersing, TH¹; Van der Voort, PHJ²; Spronk, PE³; Franssen, EJF^1
1Department of Clinical Pharmacy, OLVG, Amsterdam, The Netherlands
²Department of Intensive Care, UMCG, Groningen, The Netherlands
³Department of Intensive Care Medicine, Gelre hospitals Apeldoorn, Apeldoorn, The Netherlands

Yan M , Zou Y, Tang D, Wang Y, Xiao YW, Zhao YC, Wang F, Zhang BK, Xiang DX
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Ze-Yue Xu^a,b,†,‡, Hong-Li Guo^a,†, Ling Li^a,b,‡, Xia-Jing^a, Ze-Jun Xu^a, Jin-Chun Qiu^a, Xiao-Peng Lu^c, Feng Chen^a,*, Jing Xu^a,*, Xuan-Sheng Ding^b
a Department of Pharmacy, Children’s Hospital of Nanjing Medical University, Nanjing, China
^b School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China
^c Department of Neurology, Children’s Hospital of Nanjing Medical University, Nanjing, China

Noda S¹, Wakasugi Y¹, Yabuta N¹, Sudou M¹, Hira D^1,2, Iida H³, Osaki R⁴, Fujimoto T⁴, Tani M³, Andoh A⁴, Morita SY¹, Terada T^1
1Department of Pharmacy, Shiga University of Medical Science Hospital
²College of Pharmaceutical Sciences, Ritsumeikan University
³ Department of Surgery, Shiga University of Medical Science Hospital
⁴Department of Gastroenterology, Shiga University of Medical Science Hospital

Tafzi N ^a, Picard N ^b, Woillard JB ^b, Fleytoux A ^a, Marquet P ^b.
^aDepartment of Pharmacology, Toxicology and Pharmacovigilance, CHU Limoges, Limoges (France)
^bDepartment of Pharmacology, Toxicology And Pharmacovigilance, CHU Limoges, Limoges, (France) and University of Limoges, Inserm, UMR IPPRITT 1248, Limoges(France)

Salvatore J. Salamone¹, Mary Rose Hilaire¹, Nathan A. Siegfried¹, Ashwini Sumanth¹, Dan Kozo¹, Regina Gill¹, Kristin DiStefano¹, Rebecca Harney¹, Justin Jarrah¹, Jodi Courtney¹, Irina Baburina^1
1Saladax Biomedical, Inc.

Yan M , Zou Y, Xiao YW, Wang F, Luo H , Zhang BK
The Second Xiangya Hospital of Central South University, Changsha, Hunan , China

Makiko T ¹, Tomoyuki M ^{2, 3}, Kei I^{1, 4}, Hiroyuki O ¹, Masaki H ¹, Hiroaki I ¹, Nobuyuki M ¹, Masaaki E ⁵, Shoji F ⁴, Keisuke T ⁶ and Tohru H ^1
1 Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan.
² Division of Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA.
³ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
⁴ Faculty of Pharmaceutical Sciences, Kobe Gakuin University, Kobe, Japan.
⁵ Department of Clinical Laboratory Technology, Kobe City Medical Center General Hospital, Kobe, Japan.
⁶ Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan.

Jing Yan^1,2, Hongwei Peng^1,2,#
1Department of Pharmacy, First Affiliated Hospital of Nanchang University, China;
²Department of Pharmacy, Medical School of Nanchang University, Nanchang, China;
^#Correspondence

Bethlehem, PharmD^a; L.E.J. Peeters, PharmD^a,b; I.T. Vleut, MSc^a; G.E. Tan, MD^c; E.A. Croes MD PhD ^d
aErasmus MC, University Medical Center Rotterdam, Department of Hospital Pharmacy, The Netherlands
^bErasmus MC, University Medical Center Rotterdam, Department of Internal Medicine, The Netherlands
^cPublic Health Service (GGD) region Utrecht
^d Trimbos Institute, Utrecht, The Netherlands

 Yan M, Zhao YC, Lin XB, Zhang BK
The Second Xiangya Hospital of Central South University, Changsha, Hunan, China

Noceti O¹; Deleón N¹; Woillard J-B²; Viñoly MC¹; Gerona S¹.
¹Liver Diseases Department, National Center for Liver Transplantation, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay.
²U1248 INSERM, IPPRITT Univ. Limoges, France.

Zhang, X ^[1], MacDonald, A.M.^[2], Ye, J ^[1], Huang D.Y.^[1],  Charleton, C.^[3], Huestis, M.^[4] and Kinniburgh, D.W.^[1]
[1]Alberta Centre for Toxicology (ACFT), Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada, ^[2] Health and Environments Research Centre Laboratory, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada, ^[3]Public Health Laboratories, Alberta Health Service, Edmonton, Alberta, Canada, ^[4]Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA, USA

Zwart TC (1), Metscher E (1), Gokoel SRM (2), van der Boog PJM (2), de Fijter JW (2), Guchelaar HJ (1,3), Swen JJ (1,3), de Vries APJ (2), Moes DJAR (1,3)
(1) Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
(2) Department of Internal Medicine (Nephrology and LUMC Transplant Center), Leiden University Medical Center, Leiden, The Netherlands.
(3) Leiden Network for Personalized Therapeutics, Leiden, The Netherlands.

Pérez Montilla, CA¹; Fleitas, UE²; Marson, ME²; Fernández, ML³; García Bournissen, F^4
1Instituto Multidisciplinario de Investigaciones en Patologías Pediátricas, Consejo Nacional de Investigaciones Científicas y Técnicas (IMIPP-CONICET), Servicio de Parasitología y Chagas, Hospital de Niños “Dr. Ricardo Gutiérrez”. Buenos Aires, Argentina. ²Área de Toxicología, Departamento de Ciencias Biológicas, Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP-CONICET). Buenos Aires, Argentina. ³Instituto Nacional de Parasitología “Dr. Mario Fatala Chaben”, ANLIS “Dr. Carlos G. Malbrán”, Hospital de Infecciosas “Dr. Francisco Javier Muñiz”. Buenos Aires, Argentina. ⁴Division of Paediatric Clinical Pharmacology, Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University. London, Ontario, Canada.

Darragh J., Dhanoa S., Rodríguez M.L., McConnell R.I., FitzGerald S.P.
Randox Toxicology Ltd., Crumlin, United Kingdom

Mathew BS, Sumith Mathew, Santosh Varughese^*, David VG^*, Jeyaseelan L^$, Ratna Prabha, Blessed Winston, John GT^#
– Dept.of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, Tamil Nadu, India
^* – Dept. of Nephrology, Christian Medical College, Vellore, Tamil Nadu, India
^$ – Dept. of Biostatistics, Christian Medical College, Vellore, Tamil Nadu, India
^# – Kidney Health Service, Royal Brisbane and Women’s Hospital, Brisbane, Australia

Suzuki Y¹, Sasamoto Y¹, Koyama T², Yoshijima C¹, Ohno K^1
1Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, Japan
²Department of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Japan

Smeets TJL¹, van der Sijs IH¹, de Winter BCM¹, Ruijgrok EJ^1
1Department of Hospital Pharmacy, Erasmus MC University Medical Center Rotterdam, Doctor Molewaterplein 40, 3015 GD Rotterdam, the Netherlands

P. Marquet^1,2, F. Cros¹, L. Micallef¹, E. Jaqz-Aigrain, J.B. Woillard^1,2, C. Monchaud^1,2, F. Saint-Marcoux^1,2, J. Debord^1,2.
¹ Department of Pharmacology and Toxicology, CHU Limoges, Limoges, France.
² IPPRITT, Univ. Limoges, INSERM, Limoges, France.
³ Department of Paediatric Pharmacology and Pharmacogenetics, Robert Debré Hospital, APHP, Paris, France; University Paris Diderot Sorbonne Paris Cité, Paris, France; Clinical Investigation Center CIC1426, INSERM, Paris, France.

Laura E.J. Peeters, PharmD^a,b, Lida Feyz, MD^c; Eric Boersma, PhD^c, Joost Daemen, MD, PhD^c; Teun van Gelder MD, PhD^a,b; Birgit C.P. Koch PharmD, PhD^b; Jorie Versmissen, MD, PhD^a
a  Erasmus MC, University Medical Center Rotterdam, Department of Hospital Pharmacy, The Netherlands
^b  Erasmus MC, University Medical Center Rotterdam, Department of Internal Medicine, The Netherlands
^c  Erasmus MC, University Medical Center Rotterdam, Department of Cardiology, The Netherlands

Jenkins A,^{1, 2} Amato R¹ and Xiong Y^2
1Quest Diagnostics, Marlborough, MA and ²UMass Memorial Medical Center, Worcester, MA

Endres K, Haen E
Clinical Pharmacology, Departement of Psychiatry and Psychotherapy and Departement of Pharmacology and Toxicology at the University of Regensburg; Institut AGATE, Pentling

Tewthanom K¹ Tunwongsa K ²
1 Faculty of Pharmacy, Silpakorn University, NakhonPathom, Thailand, 73000
2 Department of Pharmacy, Queen Savang Vadhana Memorial Hospital, Chonburi, Thailand 20110

Wu Y¹, Yu D², Zhang L², Sun Q², Yu H², Shi T^1
1Department of Pharmacy, ²Department of Cardiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001,P.R. China

Tron C^a, Vermond N^a, Lièvre A^b, Le Sourd S^c, Edeline J^c, Jary A^d, Quillien V^e, Bellissant E^a, Verdier MC^a, Lemaitre F^a
aDepartment of clinical and biological pharmacology and pharmacovigilance, pharmacoepidemiology and drug information center, Rennes University Hospital – Rennes (France)
^bDepartment of gastro-enterology, Rennes University Hospital – Rennes (France)
^cDepartment of medical oncology, Centre Eugène Marquis – Rennes (France)
^dDepartment of pharmacy, Centre Eugène Marquis – Rennes (France)
^eDepartment of biology, Centre Eugène Marquis -Rennes (France)

Ludovic Micallef, Caroline Monchaud, Jean-Baptiste Woillard, Franck Saint-Marcoux, Pierre Marquet
Department of Pharmacology and Toxicology, CHU Limoges, France
And the IPPRITT research unit, INSERM, University of Limoges, France

Dhruva A1, Mathew S1, Winston B1, Prabha R1, David V2, Mathew B1
1. Department of Pharmacology & Clinical Pharmacology, Christian Medical College, Vellore
2. Department of Nephrology, Christian Medical College, Vellore

Cunio C.^{1, 2}, Uster D.³ Carland J.E.^{1, 2}, Buscher H.^1,4, Liu, Z⁵, Brett J.^{1, 2}, Stefani M.^{1, 2}, Jones G.^1,6 Day R.O.^1,2,7, Wicha S.³,  Stocker S.L.^{1, 2
1}St Vincent’s Clinical School, The University of New South Wales, Sydney, Australia.
²Department of Clinical Pharmacology and Toxicology, St Vincent’s Hospital Sydney, Sydney, Australia
³University of Hamburg, Institute of Pharmacy, Hamburg, Germany
⁴Intensive Care Medicine, St Vincent’s Hospital Sydney, Sydney, Australia
⁵Stats Central, The University of New South Wales, Sydney, Australia
⁶Sydpath, St Vincent’s Hospital Sydney, Sydney, Australia
⁷School of Medical Sciences, The University of New South Wales, Sydney, Australia

Hoste E^1,2, Paquot A³, Panin N², Giulio G. Muccioli³, Haufroid V^2,4, Elens L¹.
¹ Integrated PharmacoMetrics, pharmacoGenomics and pharmacokinetics, LDRI, UCLouvain, Belgium.
² Louvain Center for for Toxicology and Applied Pharmacology, IREC, UCLouvain, Belgium.
³ Bioanalysis and Pharmacology of Bioactive Lipids, LDRI, UCLouvain, Belgium.
⁴ Department of Clinical Chemistry, Saint-Luc university clinics, Belgium

Ravinesh Mishra^1,2*, Anees A Siddiqui^2
1School of Pharmacy & Emerging Sciences, Baddi University of Emerging Sciences & Technology, Baddi (Solan), Himachal Pradesh-173 205, India; ²Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Jamia Hamdard, New Delhi 110062, India.

Paniagua-González L¹, Díaz-Louzao C², Lendoiro E¹, Otero-Antón E³, Cadarso-Suárez C², López-Rivadulla M¹, Cruz A¹, de-Castro-Ríos A^1
1Toxicology Service, Institute of Forensic Sciences, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
²Department of Statistics, Mathematical Analysis and Optimization, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
³Abdominal Trasplant Unit, Universitary Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain